Oskira-2: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Disease-Modifying Antirheumatic Drugs.

Dawes, Peter; Dimic, Aleksandar N; Genovese, Mark C; van, der Heijde Desiree; Jenkins, Martin; O'Brien, Chris; Oemar, Barry; Vencovsky, Jiri; Weinblatt, Michael

Results

eNauka > Results > Oskira-2: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Disease-Modifying Antirheumatic Drugs.

Title:	Oskira-2: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Disease-Modifying Antirheumatic Drugs.
Authors:	Dawes, Peter; Dimic, Aleksandar N; Genovese, Mark C; van, der Heijde Desiree; Jenkins, Martin; O'Brien, Chris; Oemar, Barry; Vencovsky, Jiri; Weinblatt, Michael
Issue Date:	2013
Publication:	ARTHRITIS AND RHEUMATISM
ISSN:	0004-3591 Arthritis and Rheumatism Search Idenfier
Type:	Conference Paper
Collation:	vol. 65 str. S198-S199
WoS-ID:	000325359201454
URI:	https://enauka.gov.rs/handle/123456789/819606
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

13
WEB OF SCIENCE^TM

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM